(ACS) Affiliated Computer Systems is up on talks being indicated for a merger by Cerberus Capital private equity; indicated up $8.00 to $59.00+.
(ADBE) Adobe reports after the close ($0.29/$655.5M est.).
(ALVR) Alvarion chosen by Enforta for 6 city broadband wireless access solutions.
(BCSI) Bluecoat Systems wins pact from Philips Electronics (China unit).
(CORT) Corcept Therapeutics announced Phase 3 study evaluating CORLUX(R) for Psychotic Major Depression missed its primary endpoint.
(CRZO) Carrizo Oil & Gas $0.18 EPS vs $0.14e.
(CSIQ) Canadian Solar won a contract to supply BIPV solar glass roof system to China’s Luoyang polysilicon company.
(CTIC) Cell Therapeutics files for special protocol assessment for XYOTAX PGT307 lung cancer trial in women.
(ECIL) ECI Telecom said it may see $55M to $70M in gains after completion of the Veraz Networks IPO.
(EW) Edwards Lifesciences received approval to start transcatheter heart valve pivotal trial.
(FDS) Factset $0.49 EPS vs $0.48e; guides slightly higher.
(GNVC) Genvec Signs cooperative R&D agreement with the National Institute of Allergy and Infectious Diseases to develop RSV vaccines.
(ISLN) Isilon Systems won 2 government orders.
(ITMN) Intermune announced $40 to $50 million in operating expense reduction via 50% workforce layoffs.
(JEC) Jacobs Engineering won a $550 Million government contract.
(LB) LaBarge wins $4.4 million order from for mine information systems.
(LEND) Accredited Home Lenders announces $200 million term loan commitment from Farallon Capital Management.
(MOGN) MGI Pharma announces "positive results" from a Pivotal Phase 3 Study of Aquavan for bronchoscopy.
(MYGN) Myriad Genetics announces that it has completed enrollment of patients in its global Phase 3 trial of Flurizan in Alzheimer’s disease.
(ORCL) Oracle reports after the close ($0.23/$4.33B est).
(PALM) Palm is trading up 10% on more talk of a merger offer coming from either Nokia or Motorola.
(PRGS) Progress Software $0.37 EPS vs $0.35e.
(PTIE) Pain Therapeutics said it has been cleared to initiate Phase I study in metastatic melanoma.
(TMIC) Trend Micro will repurchase 1 million shares in the next two weeks.
Jon C. Ogg
March 20, 2007
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
